Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

~15 mi. (Créteil, France, +140 more cities)

A.P.H. Paris, Hopital Henri Mondor ( Site 0179)

Hepatocellular Carcinoma

lenvatinib, +2 more drugs

chemotherapy, +2 more types

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

~15 mi. (Créteil, France, +130 more cities)

HENRI MONDOR HOSPITAL ( Site 1357)

Bladder Urothelial Carcinoma

BCG solution, +1 more drug

immunotherapy

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)

~15 mi. (Créteil, France, +131 more cities)

Hopital Henri Mondor ( Site 1105)

HER2 Negative

Adenocarcinoma of the Gastroesophageal Junction, +2 more conditions

CAPOX regimen, +3 more drugs

chemotherapy, +2 more types

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

~15 mi. (Créteil, France, +190 more cities)

Hopital Henri Mondor

ATM Loss, +27 more biomarkers

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

~15 mi. (Créteil, France, +228 more cities)

Centre Hosp Intercommunal de Creteil /ID# 227108

MET Expression

Non-Small Cell Lung Carcinoma

telisotuzumab vedotin

chemotherapy, +1 more type

Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations

~15 mi. (Créteil, France, +104 more cities)

Hopital Henri Mondor

FGFR2 Fusion

Cholangiocarcinoma

infigratinib

targeted therapy

A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

~15 mi. (Créteil, France, +87 more cities)

Centre Hospitalier Intercommunal de Creteil

ALK Fusion

Non-Small Cell Lung Carcinoma

brigatinib

targeted therapy

Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas

~15 mi. (Créteil, France, +17 more cities)

Hopital Henri Mondor

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, +7 more conditions

HMPL 689

targeted therapy

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

~17 mi. (Bobigny, France, +158 more cities)

Hopital Avicenne ( Site 0803)

Non-Small Cell Lung Carcinoma

olaparib, +4 more drugs

chemotherapy, +3 more types

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

~17 mi. (Bobigny, France, +122 more cities)

Hopital Avicenne ( Site 1106)

Small Cell Lung Carcinoma

etoposide, +5 more drugs

chemotherapy, +3 more types

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

~17 mi. (Bobigny, France, +137 more cities)

Hopital Avicenne ( Site 0358)

Skin Squamous Cell Carcinoma

pembrolizumab

immunotherapy

A Study of Oral Venetoclax Tablets and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy

~17 mi. (Bobigny, France, +197 more cities)

Hopital Avicenne - APHP /ID# 215152

BCR-ABL1 Fusion, +47 more biomarkers

Acute Myeloid Leukemia

azacitidine, +1 more drug

chemotherapy